Disclosure Panels Details Page
Esophageal/Gastric Cancers Panel - Disclosures as of 08/17/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Jaffer Ajani MD | Amgen Inc. Astellas Pharma US, Inc. Bristol Myers Squibb Delta Fly Pharma Gilead Sciences, Inc. LaNova Leap Merck & Co., Inc. miracogne NIT Prolinx Roche Laboratories, Inc. Taiho Pharmaceuticals Co., Ltd. Zymeworks |
Amgen Inc. ARCUS Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP BeiGene Boehringer Ingelheim GmbH Bristol Myers Squibb Daiichi- Sankyo Co. DAVA/OM Geneos Gilead Sciences, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Servier STEBA Turning Point zymeworks |
Chimeric | None | ✔ |
| David Bentrem MD, MS | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Joseph Chao MD | Brooklyn Immunotherapeutics Daiichi- Sankyo Co. Merck & Co., Inc. Yiviva |
Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Coherus Biosciences Eli Lilly and Company Geneos Merck & Co., Inc. Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. Silverback Therapeutics Turning Point Therapeutics |
Bristol Myers Squibb Merck & Co., Inc. |
None | ✔ |
| David Cooke MD, FACS | None | None | None | None | ✔ |
| Carlos Corvera MD, FACS | None | None | None | None | - |
| Eileen Cucinotta | None | None | None | None | - |
| Thomas D'Amico MD | None | None | None | None | ✔ |
| Prajnan Das MD, MPH, MS | None | None | None | None | - |
| Peter Enzinger MD | None | ALX Oncology Arcus Bioscience Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Blueprint Medicines Bristol Myers Squibb Chimeric Therapeutics Coherus Daiichi- Sankyo Co. Ideaya Istari Legend Loxo MSD Novartis Pharmaceuticals Corporation Ono Servier Turning Point Therapeutics Xencor Zymeworks |
None | None | - |
| Thomas Enzler MD, PhD | None | None | None | None | ✔ |
| Paul Fanta MD | None | None | None | None | ✔ |
| Farhood Farjah MD | National Cancer Institute PCORI |
None | None | None | ✔ |
| Tanya Fischer MEd, MLIS | None | None | None | None | - |
| Hans Gerdes MD | None | None | None | None | - |
| Michael Gibson MD, PhD, FACP | AbbVie, Inc. Soligenix |
Daiichi- Sankyo Co. Flagship Biosciences Merck & Co., Inc. National Cancer Institute UpToDate |
Bristol Myers Squibb | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Wayne Hofstetter MD | None | None | None | None | - |
| David Ilson MD, PhD | None | Amgen Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Bristol Myers Squibb Daiichi- Sankyo Co. Eli Lilly and Company Merck & Co., Inc. Roche Laboratories, Inc. Taiho Pharmaceuticals Co., Ltd. |
MacroGenics Merck & Co., Inc. |
Amgen Inc. |Astellas Pharma US, Inc.|AstraZeneca Pharmaceuticals LP |Bayer HealthCare |Bristol Myers Squibb|Daiichi- Sankyo Co.|MacroGenics|Merck & Co., Inc.|Roche Laboratories, Inc.|Taiho Pharmaceuticals Co., Ltd. | ✔ |
| Shadia Jalal MD | TESARO, Inc. | ADAPTIMMUNE | None | None | ✔ |
| Rajesh Keswani MD | None | Boston Scientific Corporation Neptune Medical |
None | None | ✔ |
| Sunnie Kim MD | None | Daiichi- Sankyo Co. Merck & Co., Inc. |
None | None | ✔ |
| Lawrence Kleinberg MD | Bristol Myers Squibb Incyte Corporation Novartis Pharmaceuticals Corporation Novocure |
None | None | None | ✔ |
| Samuel Klempner MD | Leap Therapeutics | Astellas Pharma US, Inc. Bristol Myers Squibb Daiichi- Sankyo Co. Eli Lilly and Company Merck & Co., Inc. Mersana sanofi-aventis U.S. |
Eli Lilly and Company | Turning Point Therapeutics | ✔ |
| Jill Lacy MD | None | Aptitude Health ASCO Deciphera Pharmaceuticals, Inc. Equinox FirstWorld Genentech, Inc. Guidepoint Ipsen Novartis Pharmaceuticals Corporation Techspert |
None | None | ✔ |
| Frank Licciardi | None | None | None | None | ✔ |
| Quan Ly MD | None | None | None | None | ✔ |
| Kristina Matkowskyj MD, PhD | None | Amgen Inc. Astellas Pharma US, Inc. Elephas Bio Intellisphere McDowell & Morrissette, PA |
None | None | ✔ |
| Nicole McMillian MS | None | None | None | None | - |
| Michael McNamara MD | None | None | None | None | ✔ |
| Sarbajit Mukherjee MD, MS | Ipsen | None | None | Esophageal Cancer Action Network | ✔ |
| Mary Mulcahy MD | None | None | None | None | ✔ |
| Darryl Outlaw MD | None | None | OncLive - Institutional Perspectives in Cancer: Gastrointestinal Malignancies | None | ✔ |
| Sharon Park PharmD, BCOP | None | None | None | None | - |
| Kyle Perry MD | None | None | None | None | ✔ |
| Jose Pimiento MD | None | ADVOCARE, wellness company | None | None | ✔ |
| Lenora Pluchino PhD | None | None | None | None | - |
| George Poultsides MD, MS, FACS | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Scott Reznik MD | None | None | None | Onconano | ✔ |
| Robert Roses MD | None | None | None | None | ✔ |
| Vivian Strong MD | None | None | None | None | - |
| Stacey Su MD | None | None | None | None | - |
| Samantha Tamburro BSN, RN, OCN | None | None | Flatiron Health, Inc. | None | - |
| Erin Vidic | None | None | None | None | - |
| Hanlin Wang MD, PhD | PathAI | Astellas Pharma US, Inc. | None | None | ✔ |
| Georgia Wiesner MD | None | None | None | None | - |
| Christopher Willett MD | None | None | None | None | - |
| Danny Yakoub MD, PhD | None | None | None | None | - |
| Harry Yoon MD | BeiGene Boston Biomedical Bristol Myers Squibb CARsgen Elevar Macrogenics Merck & Co., Inc. |
Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP BeiGene Bristol Myers Squibb MacroGenics Novartis Pharmaceuticals Corporation OncXerna Zymeworks |
None | None | ✔ |